PD-1 high expression predicts lower local disease control in stage IV M0 nasopharyngeal carcinoma
PD-1 high expression predicts lower local disease control in stage IV M0 nasopharyngeal carcinoma
复制标题
DOI:
10.1186/s12885-019-5689-y
复制
发表时间:
2019-05-28
期刊:
影响因子:
3.8
通讯作者:
Wei, Qichun
中科院分区:
文献类型:
--
作者:
Jiang, Feng;Yu, Wei;Wei, Qichun
BackgroundTumor-infiltrating lymphocytes (TILs) play a critical role in tumor immune surveillance and immune suppression. Understanding tumor infiltrating T cell subset density, location and PD-1/PD-L1 expression might provide insight for the prediction of tumor therapeutic response and clinical outcome. The purpose of this study was to evaluate the expression and localization of CD8, FoxP3, PD-1, and PD-L1 in primary tumor tissues and their effects on prognosis of stage IV M0 locally advanced nasopharyngeal carcinoma (NPC) patients.MethodsSixty NPC patients with stage IV M0 locally advanced disease were treated with definitive chemoradiation. Tumor biopsies from primary lesion were analyzed for the expression and localization of CD8, FoxP3, PD-1, and PD-L1 by immunohistochemistry. Their associations with local disease control and survival of NPC were analyzed.ResultsThe average follow-up time was 43months (range from 14 to 61months). High expression of CD8(+,) FoxP3(+), PD-1(+) and PD-L1(+) was observed in 60, 86.7, 56.7, and 91.7% of patients, respectively. There was no correlation between clinicopathological features and the expression of these immune markers. High PD-1 expression was found to be associated with lower local disease control (5-year LRFS 23.2% vs 96.8%, p